|
US7252829B1
(en)
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
|
US20020168374A1
(en)
*
|
1992-08-07 |
2002-11-14 |
Ralph T. Kubo |
Hla binding peptides and their uses
|
|
US20040110283A1
(en)
*
|
1997-02-27 |
2004-06-10 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products
|
|
US20050170503A1
(en)
*
|
1997-02-27 |
2005-08-04 |
University Of Pittsburgh |
In vitro induction of antigen-specific T-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
|
|
US7282198B2
(en)
*
|
1997-03-19 |
2007-10-16 |
The University Of Arkansas For Medical Sciences |
Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
|
|
WO1999024554A2
(en)
|
1997-11-12 |
1999-05-20 |
University Of Pittsburgh |
Isolation, characterization, and identification of dendritic like cells and methods of using same
|
|
WO1999043710A1
(en)
*
|
1998-02-26 |
1999-09-02 |
Beckman Coulter, Inc. |
Prostate-specific membrane antigens and methods of making and using
|
|
WO1999046984A1
(en)
*
|
1998-03-20 |
1999-09-23 |
Genzyme Corporation |
Compositions and methods for the frozen storage of dendritic cells
|
|
WO1999050392A1
(en)
|
1998-03-31 |
1999-10-07 |
Geron Corporation |
Methods and compositions for eliciting an immune response to a telomerase antigen
|
|
US7402307B2
(en)
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
WO1999058678A2
(en)
*
|
1998-05-11 |
1999-11-18 |
Micromet Gmbh |
Antibodies to dendritic cells and human dendritic cell populations and uses thereof
|
|
US6495333B1
(en)
|
1998-09-22 |
2002-12-17 |
Becton Dickinson And Company |
Flow cytometric, whole blood dendritic cell immune function assay
|
|
US7351546B2
(en)
*
|
1998-09-22 |
2008-04-01 |
Becton, Dickinson And Company |
Flow cytometric, whole blood dendritic cell immune function assay
|
|
US6387888B1
(en)
|
1998-09-30 |
2002-05-14 |
American Foundation For Biological Research, Inc. |
Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen
|
|
US7807377B2
(en)
|
1998-10-20 |
2010-10-05 |
Salvatore Albani |
Method of isolating antigen-specific T cells employing artificial antigen presenting cells
|
|
US6787154B2
(en)
*
|
1998-10-20 |
2004-09-07 |
Salvatore Albani |
Artificial antigen presenting cells
|
|
HK1041433A1
(zh)
|
1998-10-20 |
2002-07-12 |
Albani Salvatore |
人工抗原特异性细胞和相关方法
|
|
GB9827103D0
(en)
*
|
1998-12-10 |
1999-02-03 |
Onyvax Ltd |
New cancer treatments
|
|
GB9827104D0
(en)
*
|
1998-12-10 |
1999-02-03 |
Onyvax Ltd |
New cancer treatments
|
|
AU3755800A
(en)
*
|
1999-03-15 |
2000-10-04 |
Introgen Therapeutics, Inc. |
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
|
|
AU4366000A
(en)
|
1999-04-14 |
2000-11-14 |
Chiron Corporation |
Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
|
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015205B1
(en)
|
1999-10-18 |
2006-03-21 |
St. Vincent's Hospital And Medical Center Of New York |
Melanoma vaccine and methods of making and using same
|
|
KR100363587B1
(ko)
*
|
1999-11-12 |
2002-12-06 |
이시우 |
대식세포와 종양세포의 융합에 의한 항종양 세포성 치료제
|
|
EP1813626B1
(en)
*
|
1999-11-15 |
2015-02-18 |
Miltenyi Biotec GmbH |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby
|
|
US7030228B1
(en)
|
1999-11-15 |
2006-04-18 |
Miltenyi Biotec Gmbh |
Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
|
|
AU1811801A
(en)
*
|
1999-12-03 |
2001-06-12 |
Dendreon Corporation |
Cryopreservation of antigen-loaded dendritic cells and their precursors in serum-free media
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
AU2001242190A1
(en)
*
|
2000-03-31 |
2001-10-15 |
Aventis Pasteur Limited |
Immunogenic peptides derived from prostate-specific membrane antigen (psma) and uses thereof
|
|
WO2001085203A2
(en)
|
2000-05-11 |
2001-11-15 |
Altarex Corp. |
Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
|
|
US20030175247A1
(en)
*
|
2000-05-12 |
2003-09-18 |
Michael Salgaller |
Method to increase class I presentation of exogenous antigens by human dendritic cells
|
|
DE10041515A1
(de)
|
2000-08-24 |
2002-03-14 |
Gerold Schuler |
Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen
|
|
EP1320602A2
(en)
*
|
2000-09-21 |
2003-06-25 |
The Regents Of The University Of California |
Spas-1 cancer antigen
|
|
AU2002232560A1
(en)
|
2000-10-27 |
2002-05-06 |
Immuno-Rx, Inc |
Vaccine immunotherapy for immune suppressed patients
|
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
|
US20070025958A1
(en)
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
WO2003008537A2
(en)
*
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Epitope sequences
|
|
CA2448599A1
(en)
*
|
2001-04-27 |
2002-11-07 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated t cells
|
|
ES2766299T3
(es)
|
2001-09-06 |
2020-06-12 |
Northwest Biotherapeutics Inc |
Composiciones y procedimientos para la activación linfocitaria de células dendríticas monocíticas y células T para generar una respuesta Th-1
|
|
WO2003033520A2
(en)
*
|
2001-09-24 |
2003-04-24 |
University Of Pittburgh Of The Commonwealth System Of Higher Education |
Anticancer vaccine and diganostic methods and reagents
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
EP1448588A4
(en)
*
|
2001-10-23 |
2006-10-25 |
Psma Dev Company L L C |
ANTIBODIES AND MULTIMERS OF PSMA PROTEINS
|
|
WO2003050140A1
(fr)
*
|
2001-12-10 |
2003-06-19 |
Kyogo Itoh |
Antigenes tumoraux
|
|
US7498171B2
(en)
|
2002-04-12 |
2009-03-03 |
Anthrogenesis Corporation |
Modulation of stem and progenitor cell differentiation, assays, and uses thereof
|
|
EP1509244B1
(en)
*
|
2002-06-06 |
2011-07-27 |
Immunicum AB |
New method and composition for producing a cellular allogeneic vaccine
|
|
RU2328317C2
(ru)
|
2002-06-19 |
2008-07-10 |
Норсуэст Байотерапьютикс, Инк |
Устройство для фильтрации тангенциального потока и способы обогащения лейкоцитов
|
|
US20040022813A1
(en)
*
|
2002-08-05 |
2004-02-05 |
Jean-Claude Bystryn |
Shed antigen vaccine with dendritic cells adjuvant
|
|
JP2004196770A
(ja)
*
|
2002-10-24 |
2004-07-15 |
Effector Cell Institute Inc |
樹状細胞前駆体の血中レベル上昇剤
|
|
KR100522526B1
(ko)
*
|
2002-11-28 |
2005-10-19 |
주식회사 바이넥스 |
면역 치료용 수지상 세포의 제조방법
|
|
ATE486125T1
(de)
*
|
2002-12-06 |
2010-11-15 |
Northwest Biotherapeutics Inc |
Verabreichung teilgereifter dendritischer zellen in vitro zur behandlung von tumoren
|
|
CA2512161A1
(en)
*
|
2003-01-28 |
2004-08-12 |
Shanghai Sunway Biotech Co., Ltd |
Hyperthermia oncolysis co-therapy
|
|
WO2004075855A2
(en)
*
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
|
JP4762887B2
(ja)
|
2003-02-27 |
2011-08-31 |
ノースウエスト バイオセラピューティクス，インコーポレイティド |
付加的なサイトカインの非存在下でｇｍ−ｃｓｆを用いる単球樹状前駆細胞からの樹状細胞の産生
|
|
US20080199484A1
(en)
*
|
2003-10-06 |
2008-08-21 |
Cedars-Sinai Medical Center |
Use Of Cox-2 Inhibitor to Prevent T-Cell Anergy Induced By Dendritic Cell Therapy
|
|
WO2005043155A1
(en)
*
|
2003-10-21 |
2005-05-12 |
Cedars-Sinai Medical Center |
System and method for the treatment of cancer, including cancers of the central nervous system
|
|
AU2005274649B2
(en)
|
2004-08-19 |
2010-09-09 |
University College Cardiff Consultants Limited |
Preparation of antigen-presenting human gamma delta T cells and use in immunotherapy
|
|
WO2006023598A2
(en)
*
|
2004-08-19 |
2006-03-02 |
University Of Maryland, Baltimore |
Prostate-specific antigen-derived mhc class ii-restricted peptides and their use in vaccines to treat or prevent prostate cancer
|
|
CN100591761C
(zh)
*
|
2004-08-19 |
2010-02-24 |
加的夫大学学院咨询有限公司 |
呈递抗原的人γδT细胞的制备和在免疫治疗中的用途
|
|
WO2007044033A2
(en)
*
|
2004-12-07 |
2007-04-19 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Therapeutic and diagnostic cloned mhc-unrestricted receptor specific for the muc1 tumor associated antigen
|
|
WO2006095330A2
(en)
*
|
2005-03-10 |
2006-09-14 |
Yeda Research And Development Co. Ltd. |
Methods and immunogenic cell preparations for treating antigen-associated diseases
|
|
CA2504279A1
(en)
*
|
2005-04-15 |
2006-10-15 |
University Of Saskatchewan |
Materials and method of modulating the immune response using t helper-antigen presenting cells
|
|
EP1888105A2
(en)
*
|
2005-05-12 |
2008-02-20 |
Introgen Therapeutics, Inc. |
P53 vaccines for the treatment of cancers
|
|
US7999088B2
(en)
|
2005-06-17 |
2011-08-16 |
Mannkind Corporation |
Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
|
|
US8338173B2
(en)
*
|
2005-08-11 |
2012-12-25 |
University College Cardiff Consultants Limited |
Preparation of antigen-presenting human γδ T cells and use in immunotherapy
|
|
CA2632263C
(en)
*
|
2005-12-08 |
2022-01-11 |
Northwest Biotherapeutics, Inc. |
Compositions and methods for inducing the activation of immature monocytic dendritic cells
|
|
US20100196336A1
(en)
|
2006-05-23 |
2010-08-05 |
Dongsu Park |
Modified dendritic cells having enhanced survival and immunogenicity and related compositions and methods
|
|
CA2700573C
(en)
|
2006-09-26 |
2016-11-22 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
|
US8097256B2
(en)
|
2006-09-28 |
2012-01-17 |
Cedars-Sinai Medical Center |
Cancer vaccines and vaccination methods
|
|
WO2008127285A2
(en)
*
|
2006-10-05 |
2008-10-23 |
The Board Of Trustees Of The University Of Arkansas |
Target peptides for ovarian cancer immunotherapy
|
|
CA2706445C
(en)
|
2007-11-28 |
2019-07-23 |
Irx Therapeutics, Inc. |
Production of apoptosis-resistant t-lymphocytes for use in cancer therapy
|
|
CA2721169A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Proscan Rx Pharma Inc. |
Prostate specific membrane antigen antibodies and antigen binding fragments
|
|
WO2010011994A2
(en)
|
2008-07-25 |
2010-01-28 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Polypeptides and uses thereof
|
|
DK2328923T3
(en)
|
2008-09-02 |
2016-03-21 |
Cedars Sinai Medical Center |
CD133 epitopes
|
|
PL2326350T3
(pl)
|
2008-09-08 |
2014-03-31 |
Psma Dev Company L L C |
Związki do zabijania eksprymujących PSMA, opornych na taksan komórek rakowych
|
|
JP6069755B2
(ja)
|
2008-11-24 |
2017-02-01 |
ヘルムホルツ・ツェントルム・ミュンヘン・ドイチェス・フォーシュンクスツェントルム・フュア・ゲズントハイト・ウント・ウンベルト・ゲーエムベーハー |
高親和性ｔ細胞受容体およびその用途
|
|
DK2427485T3
(en)
|
2009-05-07 |
2017-03-13 |
Immunocellular Therapeutics Ltd |
CD133 epitopes
|
|
ES2679043T3
(es)
|
2009-05-15 |
2018-08-21 |
Irx Therapeutics, Inc. |
Inmunoterapia de vacuna
|
|
AU2010328197B2
(en)
|
2009-12-08 |
2015-07-16 |
Irx Therapeutics, Inc. |
Method of reversing immune suppression of Langerhans cells
|
|
US20110251128A1
(en)
*
|
2010-02-26 |
2011-10-13 |
The Board Of Regents Of The University Of Texas System |
THYMOSIN Beta4 PEPTIDES PROMOTE TISSUE REGENERATION
|
|
US9629357B2
(en)
*
|
2013-02-01 |
2017-04-25 |
Primegen Biotech Llc |
Cryopreservation of cells and tissue for clinical application
|
|
US20140234351A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd. |
Cancer vaccines and vaccination methods
|
|
US10320290B2
(en)
*
|
2013-08-09 |
2019-06-11 |
Microsemi Corporation |
Voltage regulator with switching and low dropout modes
|
|
EP3277325B1
(en)
|
2015-04-03 |
2020-10-28 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Combination immunotherapy for cancer
|
|
KR102873947B1
(ko)
|
2015-05-07 |
2025-10-22 |
베이롤 칼리지 오브 메드신 |
수지상 세포 면역요법
|
|
WO2017087763A1
(en)
|
2015-11-18 |
2017-05-26 |
Orbis Health Solutions Llc |
T7 alpha viral vector system
|
|
US11020465B2
(en)
|
2016-03-04 |
2021-06-01 |
The Trustees Of Columbia University In The City Of New York |
Development of dual whole cell-based vaccine against pancreatic cancer
|
|
WO2017181163A2
(en)
|
2016-04-16 |
2017-10-19 |
Oncocyte Corporation |
Methods and compositions for detection and diagnosis of breast cancer
|
|
WO2020032782A1
(ko)
*
|
2018-08-10 |
2020-02-13 |
주식회사 유틸렉스 |
암항원 특이적 cd8+ t 세포의 제조 및 동결보존 방법
|